Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

Author:

Mettke, F.; Schlevogt, B.; Deterding, K.; Wranke, A.; Smith, A.; Port, K.; Manns, M. P.; Vogel, A.; Cornberg, M.; Wedemeyer, H.

Tübinger Autor(en):

Published in:

Alimentary Pharmacology & Therapeutics (2018), Bd. 47, H. 4, S. 516-525

Verlagsangabe:

Wiley

Language:

English

Full text:

ISSN:

1365-2036

DDC Classifikation:

610 - Medicine and health

Dokumentart:

Article

This item appears in the following Collection(s)